RADI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 4.232
AS - Asia 3.621
EU - Europa 2.533
SA - Sud America 566
AF - Africa 244
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 11.202
Nazione #
US - Stati Uniti d'America 4.114
SG - Singapore 1.396
CN - Cina 1.234
SE - Svezia 485
IE - Irlanda 479
IT - Italia 460
BR - Brasile 455
DE - Germania 292
HK - Hong Kong 285
FI - Finlandia 222
TR - Turchia 198
VN - Vietnam 180
NL - Olanda 128
UA - Ucraina 127
ZA - Sudafrica 117
CI - Costa d'Avorio 98
RU - Federazione Russa 88
IN - India 83
KR - Corea 82
CA - Canada 81
GB - Regno Unito 65
FR - Francia 59
AR - Argentina 53
JP - Giappone 29
ID - Indonesia 27
ES - Italia 26
BD - Bangladesh 21
BE - Belgio 20
MX - Messico 20
PL - Polonia 20
EC - Ecuador 15
IQ - Iraq 14
AT - Austria 13
CZ - Repubblica Ceca 13
CO - Colombia 12
PK - Pakistan 10
CL - Cile 9
NP - Nepal 8
LT - Lituania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
NG - Nigeria 6
RS - Serbia 6
UZ - Uzbekistan 6
VE - Venezuela 6
JM - Giamaica 5
PE - Perù 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
EU - Europa 4
KZ - Kazakistan 4
MA - Marocco 4
AM - Armenia 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
LB - Libano 3
OM - Oman 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
PA - Panama 2
PS - Palestinian Territory 2
SD - Sudan 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
Totale 11.199
Città #
Singapore 693
Ashburn 503
Chandler 488
Dublin 477
Santa Clara 304
Jacksonville 285
Hong Kong 279
Beijing 270
Dallas 242
Boardman 179
Dearborn 174
Izmir 171
Ann Arbor 140
Nanjing 138
Parma 137
Johannesburg 109
Abidjan 98
Princeton 88
Hefei 87
Ho Chi Minh City 86
Chicago 80
Seoul 71
Columbus 69
Los Angeles 66
New York 65
Wilmington 63
Shenyang 62
Jinan 57
Grafing 56
Bengaluru 50
The Dalles 49
San Mateo 48
Toronto 48
Helsinki 45
São Paulo 45
Moscow 43
Munich 41
Nanchang 41
San Jose 38
Council Bluffs 37
Hanoi 37
Hebei 36
Tianjin 36
Woodbridge 36
Kunming 34
Shanghai 34
Seattle 32
Changsha 31
Brooklyn 29
Jiaxing 29
Des Moines 28
Guangzhou 28
Bologna 25
Hangzhou 24
Tokyo 24
Milan 22
Turku 19
Warsaw 19
Falls Church 18
Montreal 18
Zhengzhou 18
London 17
Orem 17
Houston 16
Jakarta 16
Buffalo 15
Haikou 15
Brussels 14
Fuzhou 13
Lanzhou 13
Rio de Janeiro 13
Taiyuan 13
Nuremberg 12
Amsterdam 11
Bremen 11
Düsseldorf 11
Stockholm 11
Atlanta 10
Belo Horizonte 10
Hải Dương 10
Kocaeli 10
Ningbo 10
Taizhou 10
Campinas 9
Denver 9
Frankfurt am Main 9
Fremont 9
Phoenix 9
Brasília 8
Caxias do Sul 8
Charlotte 8
Chennai 8
Curitiba 8
Istanbul 8
Manchester 8
Poplar 8
Buenos Aires 7
Norwalk 7
Pavia 7
Porto Alegre 7
Totale 7.014
Nome #
The in silico drug discovery toolbox: applications in lead discovery and optimization 216
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 185
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 173
ATP-Competitive Inhibitors of mTOR: An Update 170
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 166
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant 150
Probing the Reactivity of 2,4-Dichlorofuro[3,4-d ]pyrimidin-7-one: A Versatile and Underexploited Scaffold to Generate Substituted or Fused Pyrimidine Derivatives 148
System-Oriented Optimization of Multi-target 2,6-Diaminopurine Derivatives: Easily Accessible Broad-Spectrum Antivirals Active Against Flaviviruses, Influenza Virus and SARS-CoV-2 146
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 144
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents 144
Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue/Zika Replication 139
A one-pot, two-step microwave-assisted synthesis of highly functionalized benzoxazoles using solid-supported reagents (SSRs) 132
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of rigid pyrazolones 130
Multicomponent Synthesis of Purines and Pyrimidines: From the Origin of Life to New Sustainable Approaches for Drug-Discovery Applications 129
Microwave-enhanced Sonogashira coupling reaction of substituted pyrimidinones and pyrimidine nucleosides 129
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 125
Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones 125
6-Vinyl pyrimidine and pyrimidinone derivatives and the use thereof 125
Troxacitabine Prodrugs for Pancreatic Cancer 122
A Versatile Route to C-6 Arylmethyl-FunctionalizedS-DABO and Related Analogues 122
New insights into small-molecule inhibitors of Bcr-Abl 121
Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders 120
Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication 120
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 119
4-Amino-Substituted Pyrazolo[3,4-d]Pyrimidines: Synthesis and Biological Properties 118
Drug repurposing approaches to fight Dengue virus infection and related diseases 117
Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies 117
Exploring the chemical space around the privileged pyrazolo[3,4-d] pyrimidine scaffold: Toward novel allosteric inhibitors of T315I-mutated Abl 116
Synthesis of novel non-nucleoside and nucleoside derivatives as potential HIV-1 inhibitors 116
Synthesis of an Original Oxygenated Taxuspine X Analogue: a Versatile “Non-Natural” Natural Product with Remarkable P-gp Modulating Activity 116
A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes 116
A Multidisciplinary Approach for the Identification of Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: S-DABOCs and DAVPs 115
A one-pot two-step microwave-assisted synthesis of N1-substituted 5,6-ring-fused 2-pyridones 115
Src Kinase Inhibitors: An Update on Patented Compounds 113
A Convergent Approach for the Synthesis of Ara-Neplanocin a Analogues Under Subzero Microwave Assisted Conditions 112
Synthesis of enantiomerically pure α-[4-(1-substituted)-1,2,3-triazol-4-yl]-benzylacetamides via microwave-assisted click chemistry: towards new potential antimicrobial agents 112
Arylation of 2-Furyl 4-Fluorophenyl Ketone: An Extension of Heck Chemistry towards Novel Integrase Inhibitors 111
Dual Src and Abl inhibitors target wild type Abl and the AblT315I Imatinib-resistant mutant with different mechanisms 111
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 110
Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional Effect 110
Discovery of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Competing with the Nucleotide Substrate 110
In Vitro Optimization of Non-Small Cell Lung Cancer Activity with Troxacitabine,l-1,3-Dioxolane-cytidine, Prodrugs 110
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines 109
Design and Synthesis of Thiadiazoles and Thiazoles Targeting the Bcr-Abl T315I Mutant: from Docking False Positives to ATP-Noncompetitive Inhibitors 108
Microwave-assisted organocatalytic multicomponent Knoevenagel/hetero Diels–Alder reaction for the synthesis of 2,3-dihydropyran[2,3-c]pyrazoles 108
A microwave-assisted multicomponent protocol for the synthesis of benzofuran-2-carboxamides 108
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 108
Identification of Breast Cancer Inhibitors Specific for G Protein-Coupled Estrogen Receptor (GPER)-Expressing Cells 108
A Domino Microwave-Assisted Protocol for the Synthesis of 2,6-Disubstituted Pyrimidinones 107
Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases 106
Solid-phase synthesis (SPS) of substituted uracils via Oxone® cleavage methodology 105
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 105
Design, Synthesis, Biological Activity, and ADME Properties of Pyrazolo[3,4-d]pyrimidines Active in Hypoxic Human Leukemia Cells: A Lead Optimization Study 104
Parallel Solution-Phase Synthesis of 4-Dialkylamino-2-methylsulfonyl-6-vinylpyrimidines 103
Derivati 1,3,4-tiadiazolici metodi di preparazione e uso di essi 103
An alternative synthetic approach for the synthesis of biologically relevant 1,4-disubstituted pyrazolo[3,4-d]pyrimidines 102
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation 101
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds 101
Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR field 100
Crystal structure of HIV-1 reverse transcriptase bound to a nucleotide-competitive reverse transcriptase inhibitor and the use thereof 99
Compounds with DDX3 inhibitory activity and uses thereof 99
Toward the Discovery of Novel Anti-HIV Drugs. Second-Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti-HIV Activity: Synthesis, Structure-Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation 99
Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families 98
Crystal Structure of HIV-1 Reverse Transcriptase Bound to a Non-Nucleoside Inhibitor with a Novel Mechanism of Action 98
Computational techniques are valuable tools for the discovery of protein–protein interaction inhibitors: The 14-3-3σ case 97
Microwave-Assisted Acylation of Amines, Alcohols, and Phenols by the Use of Solid-Supported Reagents (SSRs) 97
New 4-substituted derivatives of pyrazolo[3,4-d]pyrimidines and pyrrolo[2,3-d]pyrimidines and uses thereof 96
Vascular Endothelial Growth Factor (VEGF) receptors: drugs and new inhibitors 96
Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors 96
Molecular Characterization of c-Abl/c-Src Kinase Inhibitors Targeted against Murine Tumour Progenitor Cells that Express Stem Cell Markers 94
Exploring the synthesis of masked phosphoramido 6-vinylcytidine derivatives as building blocks for cross-linking oligonucleotides 93
Nucleoside Derivatives of 2,6-Diaminopurine Antivirals: Base-Modified Nucleosides with Broad-Spectrum Antimicrobial Properties 92
Stereoselective synthesis of N1-6-methyluridine and related 2-substituted analogues 92
Identification of Potent c-Src Inhibitors Strongly Affecting the Proliferation of Human Neuroblastoma Cells 92
A Combination Strategy to Inhibit Pim-1: Synergism between Noncompetitive and ATP-Competitive Inhibitors 91
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 91
Pyazolopyrimidines: old molecules, new targets 91
Towards novel S-DABOC inhibitors: Synthesis, biological investigation, and molecular modeling studies 90
Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (S-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants 89
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d ]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma 88
Synthesis of reactive cytidine derivatives as building blocks for cross-linking oligonucleotides 88
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 87
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 86
Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1) 85
Practical One-Pot Two-Step Protocol for the Microwave-Assisted Synthesis of Highly Functionalized Rhodanine Derivatives 84
Preclinical discovery and development of maraviroc for the treatment of HIV 84
Recent highlights in the synthesis of highly functionalized pyrimidines 84
Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: Myth or real opportunity? 83
The fight against AIDS: new avenues for inhibiting reverse transcriptase (RT), an old target 82
Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant 81
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 81
Unconventional plasticity of hiv-1 reverse transcriptase: How inhibitors could open a connection "gate" between allosteric and catalytic sites 81
Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents 77
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections 76
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction 75
HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate 73
Insight into the allosteric inhibition of Abl kinase 73
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 70
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 69
Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antivirals 69
Totale 10.797
Categoria #
all - tutte 40.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 0 0 0 15 43 52 121 21 73 7
2021/2022539 7 14 15 36 39 72 48 91 28 18 13 158
2022/20231.840 192 186 130 136 140 219 34 123 587 9 58 26
2023/2024680 44 79 26 26 59 132 41 65 15 25 47 121
2024/20252.489 137 114 194 124 273 212 116 145 223 210 301 440
2025/20263.219 471 465 804 408 751 320 0 0 0 0 0 0
Totale 11.319